Abiopharma

New Form 8-K - ProPhase Labs, Inc. Filed: 2025-06-26 AccNo: 0001641172-25-016710 Size: 212 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits